The North America Lactase Market would witness market growth of 5.9% CAGR during the forecast period (2022-2028).
Premature babies may experience developmental lactose intolerance, which often gets better quickly. A very uncommon genetic disease known as congenital lactose intolerance occurs when there is little to no lactase production from birth. Although frequency rises with age, primary lactose intolerance often manifests in late adolescence or early adulthood. Additionally, lactase deficiency leads to lactose intolerance, which can be hereditary (primary congenital alactasia and primary hypolactasia) or caused by the environment (acquired or secondary hypolactasia).
Insufficient lactase levels in the duodenum's lining are the root cause of symptoms in both situations. In the lack of lactase, the disaccharide molecule lactose, which is present in milk and other dairy products, travels intact into the colon because it cannot be absorbed through the small intestinal wall into the circulation.
Colonic bacteria can metabolize lactose, and the fermentation produces a lot of gas (usually a mixture of carbon dioxide, hydrogen, and methane), which causes different abdominal symptoms. Additionally, because of the unabsorbed carbohydrates and fermentation byproducts, the colon's osmotic pressure is elevated, which results in a greater water flow into the bowels.
Lactose intolerance is rising in North America, raising the demand for dairy products lacking lactose. Consumers in North America, particularly in the United States, are well aware of the lactose intolerance condition. As a result, the demand for dairy products in the country that don't contain lactose is rising. The FDA's judgments about food standards and labeling substantially impact every dairy product, regardless of whether it is currently on the market, in development, or exists in the mind of an innovator working with cutting-edge food ingredients. The American government has established several requirements for lactose-free dairy ingredients. Additionally, the region's consumers have a high level of disposable money, making lactose-free dairy products accessible to them. Due to this, North America's lactase market would expand.
The US market dominated the North America Lactase Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $87,108 Thousands by 2028. The Canada market is poised to grow at a CAGR of 8.3% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.4% during (2022 - 2028).
Based on Application, the market is segmented into Food & Beverages and Pharmaceutical Products & Dietary Supplements. Based on Food & Beverages Type, the market is segmented into Milk, Yogurt, Cheese, Ice cream and Others. Based on Source, the market is segmented into Yeast, Fungi and Bacteria. Based on Form, the market is segmented into Liquid and Dry. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Kerry Group PLC, Koninklijke DSM N.V., DuPont de Nemours, Inc., Novozymes A/S (Novo Holdings A/S), Chr. Hansen Holding A/S, Advanced Enzyme Technologies Limited, Oenon Holdings, Inc., Mitushi Biopharma, Natural Factors, and Amano Enzyme, Inc.
Premature babies may experience developmental lactose intolerance, which often gets better quickly. A very uncommon genetic disease known as congenital lactose intolerance occurs when there is little to no lactase production from birth. Although frequency rises with age, primary lactose intolerance often manifests in late adolescence or early adulthood. Additionally, lactase deficiency leads to lactose intolerance, which can be hereditary (primary congenital alactasia and primary hypolactasia) or caused by the environment (acquired or secondary hypolactasia).
Insufficient lactase levels in the duodenum's lining are the root cause of symptoms in both situations. In the lack of lactase, the disaccharide molecule lactose, which is present in milk and other dairy products, travels intact into the colon because it cannot be absorbed through the small intestinal wall into the circulation.
Colonic bacteria can metabolize lactose, and the fermentation produces a lot of gas (usually a mixture of carbon dioxide, hydrogen, and methane), which causes different abdominal symptoms. Additionally, because of the unabsorbed carbohydrates and fermentation byproducts, the colon's osmotic pressure is elevated, which results in a greater water flow into the bowels.
Lactose intolerance is rising in North America, raising the demand for dairy products lacking lactose. Consumers in North America, particularly in the United States, are well aware of the lactose intolerance condition. As a result, the demand for dairy products in the country that don't contain lactose is rising. The FDA's judgments about food standards and labeling substantially impact every dairy product, regardless of whether it is currently on the market, in development, or exists in the mind of an innovator working with cutting-edge food ingredients. The American government has established several requirements for lactose-free dairy ingredients. Additionally, the region's consumers have a high level of disposable money, making lactose-free dairy products accessible to them. Due to this, North America's lactase market would expand.
The US market dominated the North America Lactase Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $87,108 Thousands by 2028. The Canada market is poised to grow at a CAGR of 8.3% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.4% during (2022 - 2028).
Based on Application, the market is segmented into Food & Beverages and Pharmaceutical Products & Dietary Supplements. Based on Food & Beverages Type, the market is segmented into Milk, Yogurt, Cheese, Ice cream and Others. Based on Source, the market is segmented into Yeast, Fungi and Bacteria. Based on Form, the market is segmented into Liquid and Dry. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Kerry Group PLC, Koninklijke DSM N.V., DuPont de Nemours, Inc., Novozymes A/S (Novo Holdings A/S), Chr. Hansen Holding A/S, Advanced Enzyme Technologies Limited, Oenon Holdings, Inc., Mitushi Biopharma, Natural Factors, and Amano Enzyme, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Food & Beverages
- Milk
- Yogurt
- Cheese
- Ice cream
- Others
- Pharmaceutical Products & Dietary Supplements
By Source
- Yeast
- Fungi
- Bacteria
By Form
- Liquid
- Dry
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Kerry Group PLC
- Koninklijke DSM N.V
- DuPont de Nemours, Inc
- Novozymes A/S (Novo Holdings A/S)
- Chr. Hansen Holding A/S
- Advanced Enzyme Technologies Limited
- Oenon Holdings, Inc
- Mitushi Biopharma
- Natural Factors
- Amano Enzyme, Inc
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Lactase Market, by Application
1.4.2 North America Lactase Market, by Source
1.4.3 North America Lactase Market, by Form
1.4.4 North America Lactase Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Lactase Market by Application
4.1 North America Food & Beverages Market by Country
4.2 North America Lactase Market by Food & Beverages Type
4.2.1 North America Milk Market by Country
4.2.2 North America Yogurt Market by Country
4.2.3 North America Cheese Market by Country
4.2.4 North America Ice cream Market by Country
4.2.5 North America Others Market by Country
4.3 North America Pharmaceutical Products & Dietary Supplements Market by Country
Chapter 5. North America Lactase Market by Source
5.1 North America Yeast Market by Country
5.2 North America Fungi Market by Country
5.3 North America Bacteria Market by Country
Chapter 6. North America Lactase Market by Form
6.1 North America Liquid Market by Country
6.2 North America Dry Market by Country
Chapter 7. North America Lactase Market by Country
7.1 US Lactase Market
7.1.1 US Lactase Market by Application
7.1.1.1 US Lactase Market by Food & Beverages Type
7.1.2 US Lactase Market by Source
7.1.3 US Lactase Market by Form
7.2 Canada Lactase Market
7.2.1 Canada Lactase Market by Application
7.2.1.1 Canada Lactase Market by Food & Beverages Type
7.2.2 Canada Lactase Market by Source
7.2.3 Canada Lactase Market by Form
7.3 Mexico Lactase Market
7.3.1 Mexico Lactase Market by Application
7.3.1.1 Mexico Lactase Market by Food & Beverages Type
7.3.2 Mexico Lactase Market by Source
7.3.3 Mexico Lactase Market by Form
7.4 Rest of North America Lactase Market
7.4.1 Rest of North America Lactase Market by Application
7.4.1.1 Rest of North America Lactase Market by Food & Beverages Type
7.4.2 Rest of North America Lactase Market by Source
7.4.3 Rest of North America Lactase Market by Form
Chapter 8. Company Profiles
8.1 Kerry Group PLC
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.5.3 Geographical Expansions:
8.2 Koninklijke DSM N.V.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Acquisition and Mergers:
8.3 DuPont de Nemours, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Approvals and Trials:
8.4 Novozymes A/S (Novo Holdings A/S)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisitions and Mergers:
8.4.5.2 Product Launches and Product Expansions:
8.5 Chr. Hansen Holding A/S
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segment & Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Advanced Enzyme Technologies Limited
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.7 Oenon Holdings, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.8 Mitushi Biopharma
8.8.1 Company Overview
8.9 Natural Factors
8.9.1 Company Overview
8.10. Amano Enzyme, Inc.
8.10.1 Company Overview
Companies Mentioned
- Kerry Group PLC
- Koninklijke DSM N.V.
- DuPont de Nemours, Inc.
- Novozymes A/S (Novo Holdings A/S)
- Chr. Hansen Holding A/S
- Advanced Enzyme Technologies Limited
- Oenon Holdings, Inc.
- Mitushi Biopharma
- Natural Factors
- Amano Enzyme, Inc.
Methodology
LOADING...
